Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Gossamer Bio Q1 2025 Earnings Call.
Gossamer Bio Inc. (GOSS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Octagon Capital Advisors Ting Jia | 18,350,000 | $20,185,000 | 3.91% | |
| 2. | 27,860,000 | $15,706,743 | 0.48% | ||
| 3. | 24,750,000 | $14,045,625 | 0.57% | ||
| 4. | 13,145,000 | $7,032,575 | +9% | 0.49% | |
| 5. | SilverArc Capital Devesh Gandhi | 6,320,684 | $6,952,752 | +3% | 1.42% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.67 | 372,000 | Officer, Director | 5,408,073 | 2024-06-21 | Filing | |
| $0.59 | 100,000 | Officer | 480,010 | 2024-06-18 | Filing | |
| $0.60 | 25,000 | Officer | 25,000 | 2024-06-17 | Filing | |
| $0.79 | 32,000 | Director | 32,000 | 2023-11-15 | Filing | |
| $0.56 | 200,000 | Officer | 380,010 | 2023-11-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.66 | 1,908 | Officer | 196,891 | 2024-06-24 | Filing | |
| $1.16 | 6,430 | Officer | 585,934 | 2024-03-27 | Filing | |
| $1.16 | 6,430 | Officer | 92,737 | 2024-03-27 | Filing | |
| $1.16 | 23,172 | Officer, Director | 120,293 | 2024-03-27 | Filing | |
| $1.33 | 4,018 | Officer | 198,799 | 2024-03-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,093,034 | $19,902,337 | 1.53% | |
| 2. | 32,300,000 | $17,688,577 | 0.65% | |
| 3. | 25,850 | $14,605,250 | 0.57% | |
| 4. | 22,096,000 | $12,140,280 | 0.15% | |
| 5. | 10,083,881 | $11,092,269 | 0% |
News See All
11 Best Penny Stocks to Invest in Under $1
Earlier on February 12 this year, Chief Investment Officer at Cetera Financial Group, Gene Goldman, discussed how he thinks small-caps are a good investment.
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
12 Popular Penny Stocks on Robinhood to Watch
The stock market is navigating a complex landscape influenced by geopolitical tensions, trade policies, and shifting investor sentiments. Recent developments, such as the U.S.
10 Penny Stocks With Huge Upside Potential According To Analysts
Penny stocks trade below $5 and attract investors looking for high returns with a small initial investment.
10 Hot Biotech Stocks Under $5
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
12 Best Penny Stocks to Invest in According to the Media
On December 24, Global Advisors’ managing partner, Tom Lee, shared his thoughts on the potential of small and mid-cap stocks in 2025.
13 Best Biotech Stocks To Buy Under $20
In this article, we're going to take a look at 13 best biotech stocks to buy under $20.
12 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 12 best medical stocks to buy under $10.
5 Small-Cap Stocks with High Potential
In this article, we will take a look at the 5 small-cap stocks with high potential.
Billionaire Hedge Funds
